Novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives
申请人:SANDOZ AG
公开号:EP0077754A2
公开(公告)日:1983-04-27
A 6- and/or 7-oxy-trans-1,2,3,4,4a,5,10,10a-octahydro- benzo[g]-quinoline in which the 3-position is substituted by an optionally amidated carboxy group, an optionally etherified hydroxymethyl group, a cyanomethyl group, an alkyl-or aryl-thiomethyl group or a sulfamoylamino or carbamoylamino group, or a physiologically-hydrolysable and -acceptable ester thereof. The subject compounds are useful as pharmaceuticals, in particular as prolactin secretion inhibitors, dopaminergic agents and dopamine receptor stimulating agents.
一种 6-和/或 7-氧-反式-1,2,3,4,4a,5,10,10a-八氢-苯并[g]-喹啉,其中 3-位被任选酰胺化的羧基、任选醚化的羟甲基、氰甲基、烷基或芳基-硫甲基或氨基磺酰基或氨基甲酰基取代,或被其生理上可水解和可接受的酯取代。上述化合物可用作药物,特别是催乳素分泌抑制剂、多巴胺能制剂和多巴胺受体刺激剂。